Evotec SE
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
other
SEC Category
Large accelerated filer
State of Incorporation
Germany
Country
Germany
Business Address
ESSENER BOGEN 7, HAMBURG, , 22419
Mailing Address
ESSENER BOGEN 7, HAMBURG, , 22419
Phone
49-40-560-810
Fiscal Year End
1231
EIN
000000000
Financial Overview
FY2025
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 20-F Foreign company annual report | April 8, 2026 | View on SEC |
| 6-K Foreign company current report | April 8, 2026 | View on SEC |
| 6-K Foreign company current report | April 7, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | April 6, 2026 | View on SEC |
| SCHEDULE 13D Beneficial ownership report (>5%) | March 30, 2026 | View on SEC |
| 6-K Foreign company current report | March 10, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 17, 2026 | View on SEC |
| 6-K Foreign company current report | January 16, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | January 16, 2026 | View on SEC |
| 6-K Foreign company current report | January 13, 2026 | View on SEC |
Annual Reports
20-F
April 8, 2026
- Successful execution of 'Project Horizon' to streamline operations and focus on high-margin research.
- Significant improvement in profitability with net loss reduced by €92.6 million compared to 2024.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.